Eruca Sativa Extract for Antibiotic-Resistant Bacteria
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a significant need for new antimicrobial drugs effective against emerging antibiotic-resistant Gram-positive bacteria, such as MRSA, particularly those derived from non-toxic natural components like Eruca sativa, as current treatments are inadequate.
Innovation Solution
An aqueous extract is obtained from Eruca sativa leaves, purified to remove insoluble components, standardized based on anhydrous content, and formulated in aseptic or sterile form to inhibit Gram-positive bacteria and mycoplasma growth, promote wound healing, and prevent microbial colonization.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If aqueous extract of Eruca sativa leaves is used to treat Gram-positive bacteria, then antimicrobial effectiveness is improved, but the need for purification and standardization increases process complexity
Solution Approach 1:
The patent extracts and isolates the active antimicrobial components from Eruca sativa leaves through aqueous extraction, separating the beneficial compounds from inactive plant material. This extraction process removes insoluble components while retaining water-soluble antimicrobial agents, thereby purifying the extract and standardizing its concentration for reliable therapeutic use.
Solution Approach 2:
The patent applies different processing conditions to different stages of extract preparation: initial aqueous extraction at controlled temperatures, followed by concentration at reduced pressures, and finally sterilization at elevated temperatures. Each local processing step optimizes specific quality attributes while preserving the antimicrobial effectiveness of the extract.
2Object-affected harmful factors
If natural plant extracts are used as antimicrobial agents, then toxicity is reduced, but consistency and standardization of antimicrobial activity become more difficult
Solution Approach 1:
The patent controls and standardizes critical parameters including extraction temperature (maintained below boiling point to preserve heat-sensitive compounds), concentration time, and final product concentration. By precisely controlling these parameters, the patent ensures consistent antimicrobial activity across batches while maintaining the low toxicity inherent in natural plant extracts.
Solution Approach 2:
The patent employs antimicrobial activity assays to test and evaluate each batch of extract, using the test results to adjust and optimize subsequent extraction and concentration parameters. This feedback loop ensures that each batch meets standardized antimicrobial effectiveness criteria while maintaining natural composition and low toxicity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The Eruca sativa extract effectively inhibits the growth of Gram-positive bacteria and mycoplasma, promoting wound healing and preventing microbial colonization, offering a non-toxic and sustainable antimicrobial solution.
Implementation Method 1
an aqueous extract of leaves of Eruca sativa that can be used to inhibit the growth of Gram-positive bacteria
Data Source
AI summary
The invention is directed to an aqueous extract of Eruca sativa (arugula) leaves that has antimicrobial activity on Gram-positive bacteria and mycoplasmas. The extract may be purified away from solid or insoluble components, standardized based on the weight of its non-aqueous or solid content, assayed for antimicrobial activity, and provided in an aseptic or sterile form for pharmaceutical use. It may be used to kill or inhibit the growth of microorganisms such as Gram positive bacteria, promote wound healing, or as prophylaxis against host colonization or infection by a microorganism.